| 摘要 |
A method for the personalized selection of antihypertensive therapy provides for the use of one medicine selected from the group of calcium antagonists, or beta-adrenoblockers, or inhibitors of angiotensin-converting enzyme. In addition, the content of C-reactive protein is measured by enzyme immunoassay in serum blood of the patient. Metoprolol, or Enalapril, or Amplodipin is used depending on the concentration of C-reactive protein. |
